Technical Data
E2280-12
Encephalitis, Equine, Venezuelan (VEE)
Description:
Venezuelan equine encephalitis virus is a mosquito-borne viral pathogen that causes Venezuelan equine encephalitis or encephalomyelitis (VEE). VEE can affect all equine species, such as horses, donkeys, and zebras. After infection, equines may suddenly die or show progressive central nervous system disorders.

Applications:
Suitable for use in ELISA, Indirect Immunohistochemistry and Neutralization. Other applications not tested.

Recommended Dilutions:
Optimal dilution determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG2a2Q2097Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceMouse
Concentration:
~1mg/ml
Immunogen:
Venezuelan Equine Encephalitis (VEE) strain PTF-39.
Purity:
Purified
Form
Supplied as a liquid.
Specificity:
Recognizes Encephalitis, Equine, Venezuelan (VEE), strain PTF-39. Crossreactive across the VEE group.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Roehrig, J.T. and Mathews, J.H. (1985). The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology 142: 347356.